GeneMatrix Inc. (109820.KQ)
KOSDAQ · KRW · Healthcare · Diagnostics & Research
₩1,463 (+0.90%) as of
Key statistics
- Market cap
- 29.21B
- Dividend yield
- 0.00%
- 52-week range
- 1,201.00 – 2,795.00
- Beta
- 1.04
- Revenue (TTM)
- 4.72B
- Profit margin
- -44.33%
- Volume
- 3.06k
About GeneMatrix Inc.
GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment. It also provides biochemical diagnostics, such as special chemistry and general chemistry, that includes semi and full auto analyer, and calibrators and controls. The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Seongnam-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.